Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRVL vs MRNA✓SelectedUSD · MRNAMRVL vs MRNA performance historyLatest closeAs of-4.86%11/19
Stock and ETF performance explorer

MRVL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.7%
MRNA return
+159.5%
Excess return
-11.9%
Maximum drawdown
-60.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.9%+1.3%-6.1%-5.0%
7D-15.8%-13.8%-2.0%-14.5%
30D-42.4%-17.7%-24.7%-41.3%
3M-41.6%+14.3%-55.9%-43.0%
6M-21.4%+336.0%-357.4%-40.7%
YTD+63.2%+575.9%-512.7%+10.2%
1Y+70.6%+724.4%-653.8%+9.4%
All+147.7%+159.5%-11.9%+90.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling